Developing Precision Therapies to Treat Neurologic Diseases
Praxis is developing therapies to address the underlying drivers of disorders characterized by neuronal dysfunction and hyperexcitability. Our portfolio currently spans essential tremor (ET), developmental and epileptic encephalopathies (DEEs), and epilepsy, with programs informed by human genetics and the biological mechanisms driving disease. Explore our resources below to learn how we are working to bring new treatment options to people living with these complex conditions.
DARE FOR MORE® For Patients
Expanding Possibilities Through Clinical Research
Learn more about Praxis’ clinical studies, including patient eligibility requirements and how to explore potential participation.
Focused on Areas of Significant Need
Learn more about the neurologic conditions we focus on and the challenges faced by patients, families, and caregivers.
Scientific Insights from Our Research
Access publications, presentations, and scientific communications that highlight our preclinical and clinical research findings.
Connect with a Medical Science Liaison
Praxis Medical Science Liaisons engage with healthcare professionals in nonpromotional scientific exchange about our research, disease areas, and investigational programs.
Healthcare professionals may use this form to request a discussion with a member of the Praxis Medical Affairs team.
"*" indicates required fields
Link to: Pipeline
Pipeline
Explore our pipeline of investigational therapies targeting biologically defined mechanisms across essential tremor, DEEs, and epilepsy.
Link to: Science
Our Science
Learn how insights from genetics, neuronal excitability, and human biology inform our approach to developing potential therapies for neurologic disorders.